Cigarette smoking and proteinuria in Taiwanese men with type 2 diabetes mellitus

Diabetic Medicine

Volumn 27, Issue 3, 2010, Pages 295-302

  Hsu, C C ^a   Hwang, S J ^b   Tai, T Y ^c   Chen, T ^d   Huang, M C ^b   Shin, S J ^b   Wen, C P ^a   Shih, Y T ^e   Yang, H J ^f   Chang, C T ^g   Chang, C J ^h   Loh, C H ⁱ   Fuh, M T ^g   Li, Y S ^a   Chang, H Y ^a  

^a NATIONAL HEALTH RESEARCH INSTITUTES   (Taiwan)

^b KAOHSIUNG MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

^c Taipei Jen Chi Relief Institute   (Taiwan)

^d TULANE UNIVERSITY   (United States)

^e TAIPEI MEDICAL UNIVERSITY   (Taiwan)

^f MIN SHENG GENERAL HOSPITAL   (Taiwan)

^g CHINA MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

^h NATIONAL CHENG KUNG UNIVERSITY HOSPITAL   (Taiwan)

ⁱ TRI SERVICE GENERAL HOSPITAL   (Taiwan)

Author keywords

Cigarette smoking; Proteinuria; Type 2 diabetes mellitus

Indexed keywords

ALBUMIN; CREATININE; GLYCOSYLATED HEMOGLOBIN;

ADULT; AGE DISTRIBUTION; AGED; ARTICLE; BLOOD PRESSURE REGULATION; CIGARETTE SMOKING; DIABETIC NEPHROPATHY; DISEASE ASSOCIATION; DISEASE DURATION; HUMAN; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; PROTEINURIA; TAIWAN; TOBACCO; BLOOD; COHORT ANALYSIS; COMPLICATION; DOSE RESPONSE; MIDDLE AGED; RISK FACTOR; SMOKING; STATISTICAL MODEL;

COHORT STUDIES; DIABETES MELLITUS, TYPE 2; DOSE-RESPONSE RELATIONSHIP, DRUG; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; LOGISTIC MODELS; MALE; MIDDLE AGED; PROTEINURIA; RISK FACTORS; SMOKING; TAIWAN;

EID: 77949346918     PISSN: 07423071     EISSN: 14645491     Source Type: Journal    
DOI: 10.1111/j.1464-5491.2010.02947.x     Document Type: Article

References (20)

1. Orth SR, Hallan SI. Smoking: a risk factor for progression of chronic kidney disease and for cardiovascular morbidity and mortality in renal patients - absence of evidence or evidence of absence? Clin J Am Soc Nephrol 2008; 3: 226-236.
2. Rossing P. Diabetic nephropathy: worldwide epidemic and effects of current treatment on natural history. Curr Diab Rep 2006; 6: 479-483.
3. Gambaro G, Bax G, Fusaro M, Normanno M, Manani SM, Zanella M et al. Cigarette smoking is a risk factor for nephropathy and its progression in type 2 diabetes mellitus. Diabetes Nutr Metab 2001; 14: 337-342.
4. Saito K, Sone H, Kawai K, Tanaka S, Kodama S, Shu M et al. Risk imparted by various parameters of smoking in Japanese men with type 2 diabetes on their development of microalbuminuria: analysis from the Tsukuba Kawai Diabetes Registry. Diabetes Care 2007; 30: 1286-1288.
5. Sawicki PT, Didjurgeit U, Muhlhauser I, Bender R, Heinemann L, Berger M. Smoking is associated with progression of diabetic nephropathy. Diabetes Care 1994; 17: 126-131.
6. Adler AI, Stevens RJ, Manley SE, Bilous RW, Cull CA, Holman RR. Development and progression of nephropathy in type 2 diabetes: the UK Prospective Diabetes Study (UKPDS 64). Kidney Int 2003; 63: 225-232.
7. Girach A, Manner D, Porta M. Diabetic microvascular complications: can patients at risk be identified? A review. Int J Clin Pract 2006; 60: 1471-1483.
8. Marshall SM, Flyvbjerg A. Prevention and early detection of vascular complications of diabetes. Br Med J 2006; 333: 475-480.
9. Levey AS, Bosch JP, Lewis JB, Greene T, Rogers N, Roth D. A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Ann Intern Med 1999; 130: 461-470.
10. Baggio B, Budakovic A, Dalla Vestra M, Saller A, Bruseghin M, Fioretto P. Effects of cigarette smoking on glomerular structure and function in type 2 diabetic patients. J Am Soc Nephrol 2002; 13: 2730-2736.
11. Chuahirun T, Simoni J, Hudson C, Seipel T, Khanna A, Harrist RB et al. Cigarette smoking exacerbates and its cessation ameliorates renal injury in type 2 diabetes. Am J Med Sci 2004; 327: 57-67.
12. Chuahirun T, Wesson DE. Cigarette smoking predicts faster progression of type 2 established diabetic nephropathy despite ACE inhibition. Am J Kidney Dis 2002; 39: 376-382.
13. De Cosmo S, Lamacchia O, Rauseo A, Viti R, Gesualdo L, Pilotti A et al. Cigarette smoking is associated with low glomerular filtration rate in male patients with type 2 diabetes. Diabetes Care 2006; 29: 2467-2470.
14. Lhotta K, Rumpelt HJ, Konig P, Mayer G, Kronenberg F. Cigarette smoking and vascular pathology in renal biopsies. Kidney Int 2002; 61: 648-654.
15. Selby JV, Swain BE, Gerzoff RB, Karter AJ, Waitzfelder BE, Brown AF et al. Understanding the gap between good processes of diabetes care and poor intermediate outcomes. Med Care 2007; 45: 1144-1153.
16. Solberg LI, Desai JR, O'Connor PJ, Bishop DB, Devlin HM. Diabetic patients who smoke: are they different? Ann Fam Med 2004; 2: 26-32.
17. Gulliford MC, Sedgwick JE, Pearce AJ. Cigarette smoking, health status, socio-economic status and access to health care in diabetes mellitus: a cross-sectional survey. BMC Health Serv Res 2003; 3: 4.
18. Wen CP, Levy DT, Cheng TY, Hsu CC, Tsai SP. Smoking behaviour in Taiwan, 2001. Tob Control 2005; 14: i51-i55.
19. Shafey O, Dolwick S, Guindon GE (eds). Tobacco Control Country Profiles 2003. Atlanta, GA: American Cancer Society, 2003.
20. Bowlin SJ, Morrill BD, Nafziger AN, Lewis C, Pearson TA. Reliability and changes in validity of self-reported cardiovascular disease risk factors using dual response: the behavioral risk factor survey. J Clin Epidemiol 1996; 49: 511-517.